Quick Answer
Harvard Apparatus Regenerative Technology, Inc. reported Revenue (ASC 606) of $704.0 thousand for fiscal year 2025.
Harvard Apparatus Regenerative Technology, Inc. Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $704.0K | +63.7% |
| 2024 | $430.0K | +317.5% |
| 2023 | $103.0K | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $123.0K | +108.5% | -61.2% |
| June 30, 2025 | $317.0K | +466.1% | +604.4% |
| March 31, 2025 | $45.0K | -21.1% | -23.7% |
| September 30, 2024 | $59.0K | +47.5% | +5.4% |
| June 30, 2024 | $56.0K | — | -1.8% |
| March 31, 2024 | $57.0K | — | +42.5% |
| September 30, 2023 | $40.0K | — | — |
- Harvard Apparatus Regenerative Technology, Inc. showed an increase of +63.7% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2023–2025 period, Harvard Apparatus Regenerative Technology, Inc.’s revenue (asc 606) has grown by 583.5% (from $103.0 thousand to $704.0 thousand).
- The most recent figure is from Harvard Apparatus Regenerative Technology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: